Dupilumab improves lung function and asthma control in patients with uncontrolled asthma


eMediNexus    30 June 2018

In a study published June 28, 2018 in the NEJM, patients with uncontrolled asthma who received dupilumab had significantly lower rates of severe asthma exacerbation vs those who received placebo. They also had better lung function and asthma control. Greater benefits were seen in patients with higher baseline levels of eosinophils.     

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.